FabWorld Today published a dedicated feature on Elevai Skincare and the science powering the shift from conventional treatments toward exosome-based regenerative skincare. They are asking a question that more and more aesthetic professionals are raising: are exosomes better and bigger than Botox?
In 2024, Fab World Today explored whether exosomes could rival Botox as the next wave in clinical skincare.
“Exosomes are being hailed as the next wave in clinical skincare.” – Fab World Today
Elevai Empower™ was highlighted as a concentrated post-procedure serum formulated for use after treatments like chemical peels, microneedling, and injectables, designed to support the skin during recovery. Elevai Enfinity™ was described as the continuing care product for daily use: a blend of Cell Zero Exosomes™ with four highly bioavailable forms of vitamin C, hyaluronic acid, and copper peptides.
This recognition reflects Elevai’s leadership in innovative, physician-dispensed skincare and our mission to bring exosome-powered solutions to patients worldwide. Read the full article on Fabworld Today.